Wang H - Search Results

1

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.

Li B, Shen S, You S, Zhang G, Gao S, Shi X, Wang H, Yin X, Xu X, Guo S, Jin G. Li B, et al. Among authors: wang h. BMC Cancer. 2021 May 26;21(1):612. doi: 10.1186/s12885-021-08380-9. BMC Cancer. 2021. PMID: 34034684 Free PMC article.

2

Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.

Li J, Li B, Jiang Q, Zhang Y, Liu A, Wang H, Zhang J, Qin Q, Hong Z, Li BA. Li J, et al. Among authors: wang h. Gene. 2018 Nov 30;677:211-227. doi: 10.1016/j.gene.2018.07.070. Epub 2018 Jul 29. Gene. 2018. PMID: 30059751 Review.

3

Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.

Guo S, Gao S, Liu R, Shen J, Shi X, Bai S, Wang H, Zheng K, Shao Z, Liang C, Peng S, Jin G. Guo S, et al. Among authors: wang h. FASEB J. 2019 Jan;33(1):873-884. doi: 10.1096/fj.201800617R. Epub 2018 Aug 9. FASEB J. 2019. PMID: 30091943

-Guo, S., Gao, S., Liu, R., Shen, J., Shi, X., Bai, S., Wang, H., Zheng, K., Shao, Z., Liang, C., Peng, S., Jin, G. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer....

-Guo, S., Gao, S., Liu, R., Shen, J., Shi, X., Bai, S., Wang, H., Zheng, K., Shao, Z., Liang, C., Peng, S., Jin, G. Oncologica …

4

Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients.

Guo S, Shi X, Shen J, Gao S, Wang H, Shen S, Pan Y, Li B, Xu X, Shao Z, Jin G. Guo S, et al. Among authors: wang h. Br J Cancer. 2020 Mar;122(6):857-867. doi: 10.1038/s41416-019-0704-2. Epub 2020 Jan 23. Br J Cancer. 2020. PMID: 31969677 Free PMC article.

5

A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.

Guo SW, Shen J, Gao JH, Shi XH, Gao SZ, Wang H, Li B, Yuan WL, Lin L, Jin G. Guo SW, et al. Among authors: wang h. Surgery. 2020 Dec;168(6):1003-1014. doi: 10.1016/j.surg.2020.02.013. Epub 2020 Apr 19. Surgery. 2020. PMID: 32321665

6

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial.

Jiang H, Zheng Y, Qian J, Mao C, Xu X, Li N, Xiao C, Wang H, Teng L, Zhou H, Wang S, Zhu D, Peng B, Shen L, Xu N. Jiang H, et al. Among authors: wang h, wang s. BMC Cancer. 2020 Aug 14;20(1):760. doi: 10.1186/s12885-020-07251-z. BMC Cancer. 2020. PMID: 32795349 Free PMC article. Clinical Trial.

7

Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing.

Zheng K, Liu T, Zhao J, Meng P, Bian Y, Ni C, Wang H, Pan Y, Wu S, Jiang H, Jin G. Zheng K, et al. Among authors: wang h. Exp Ther Med. 2021 May;21(5):415. doi: 10.3892/etm.2021.9859. Epub 2021 Feb 25. Exp Ther Med. 2021. PMID: 33747156 Free PMC article.

8

The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients.

Guo S, Shi X, Gao S, Hou Q, Jiang L, Li B, Shen J, Wang H, Shen S, Zhang G, Pan Y, Liu W, Xu X, Zheng K, Shao Z, Jing W, Lin L, Li G, Jin G. Guo S, et al. Among authors: wang h. Front Oncol. 2021 Jul 22;11:717989. doi: 10.3389/fonc.2021.717989. eCollection 2021. Front Oncol. 2021. PMID: 34368001 Free PMC article.

9

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G. Guo S, et al. Among authors: wang h. Clin Transl Med. 2021 Sep;11(9):e520. doi: 10.1002/ctm2.520. Clin Transl Med. 2021. PMID: 34586739 Free PMC article.

10

Large-cohort humanized NPI mice reconstituted with CD34⁺ hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy.

Xu X, Gu H, Li H, Gao S, Shi X, Shen J, Li B, Wang H, Zheng K, Shao Z, Cheng P, Cha Z, Peng S, Nie Y, Li Z, Guo S, Qian B, Jin G. Xu X, et al. Among authors: wang h. FASEB J. 2022 Apr;36(4):e22244. doi: 10.1096/fj.202101548RR. FASEB J. 2022. PMID: 35262964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151,499 results

Search Page

Filters